[Long-term efficacy of transhiatal esophagectomy for esophageal carcinoma and esophagogastric junction cancer].
OBJECTIVE
To evaluate the long-term efficacy of transhiatal esophagectomy (THE) for esophageal carcinoma or esophagogastric junction cancer.


METHODS
Between March 2000 and December 2009, a total of 544 patients with either esophageal carcinoma or esophagogastric junction cancer underwent esophagectomy via THE (n=63) or other approaches (n=481) in Beijing cancer hospital institution. Procedures were performed by a single surgeon team. Long-term survival was compared between two groups.


RESULTS
The 1-year, 3-year, 5-year, and 8-year accumulative survival rates in THE group were 91.0%, 60.5%, 44.6%, and 44.6%, respectively, while those in non-THE group were 84.5%, 49.2%, 37.2%, and 28.7%, respectively. The THE group showed better long-term survival than the non-THE group, however the difference was not statistically significant.


CONCLUSIONS
THE is a safe alternative for esophageal carcinoma and esophagogastric junction cancer.
Chen
Ke-neng
KN
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Thoracic Surgery I, Beijing Cancer Hospital, Peking University School of Oncology, Beijing 100142, China. chenkeneng@yahoo.com.cn
Ma
Shao-hua
SH
Liang
Zhen
Z
Kang
Xiao-zheng
XZ
D002277:Carcinoma / Q000601:surgery*; D004938:Esophageal Neoplasms / Q000601:surgery*; D016629:Esophagectomy / Q000379:methods*; D004943:Esophagogastric Junction / Q000601:surgery; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000601:surgery*; D015996:Survival Rate; D016896:Treatment Outcome